<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Yonsei Med. J</journal-id>
      <journal-id journal-id-type="publisher-id">YMJ</journal-id>
      <journal-title-group>
        <journal-title>Yonsei Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0513-5796</issn>
      <issn pub-type="epub">1976-2437</issn>
      <publisher>
        <publisher-name>Yonsei University College of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22477014</article-id>
      <article-id pub-id-type="pmc">3343435</article-id>
      <article-id pub-id-type="doi">10.3349/ymj.2012.53.3.658</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Cardiac &amp; Cardiovascular Systems</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Male Pseudohermaphroditism Presented with Sudden Cardiac Arrest</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Shim</surname>
            <given-names>Jaemin</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hwang</surname>
            <given-names>Hye Jin</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pak</surname>
            <given-names>Hui-Nam</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Moon-Hyoung</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Joung</surname>
            <given-names>Boyoung</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Corresponding author: Dr. Boyoung Joung, Division of Cardiology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea. Tel: 82-2-2228-8460, Fax: 82-2-393-2041, <email>cby6908@yuhs.ac</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>5</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>3</month>
        <year>2012</year>
      </pub-date>
      <volume>53</volume>
      <issue>3</issue>
      <fpage>658</fpage>
      <lpage>661</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>6</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>7</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Copyright: Yonsei University College of Medicine 2012</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Torsades de Pointes is a life-threatening arrhythmia associated with a number of causes, but is very rare among endocrinologic disorders. We report a case of male pseudohermaphroditism with hyperaldosteronism due to a 17&#x3B1;-hydroxylase deficiency presented with sudden cardiac arrest.</p>
      </abstract>
      <kwd-group>
        <kwd>Torsades de Pointes</kwd>
        <kwd>pseudohermaphroditism</kwd>
        <kwd>17&#x3B1;-hydroxylase deficiency</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Deficiency of 17&#x3B1;-hydroxylase is a rare autosomal recessive disorder which causes congenital adrenal hyperplasia.<xref ref-type="bibr" rid="B1">1</xref> Defects in the synthesis of cortisol and compensatory hypersecretion of adrenocorticotropic hormone (ACTH) stimulate the synthesis of a large quantity of 11-deoxycorticosterone (DOC) and corticosterone in adrenal glands. High concentrations of DOC, which is a potent mineralocorticoid, lead to hyperaldosteronism which results in hypertension, hypokalemia, and a suppressed renin-angiotensin system. In gonads, the absence of 17&#x3B1;-hydroxylase activity prohibits the synthesis of androgens, causing pseudohermaphroditism in males and sexual infantilism with primary hypogonadism in females.<xref ref-type="bibr" rid="B2">2</xref> Aldosterone excess with subsequent hypokalemia leads to the prolongation of the QT interval,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref> which may increase the risk of fatal arrhythmias such as polymorphic ventricular tachycardia (Torsades de Pointes), although these are very rare in subjects with hyperaldosteronism. We report a case of male pseudohermaphroditism due to 17&#x3B1;-hydroxylase deficiency presented with malignant arrhythmias, Torsades de Pointes.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>The 31-year-old woman was presented to our emergency room with an episode of resuscitated sudden cardiac arrest. She suddenly collapsed at her office, where, upon arrival, the emergency medical technician documented no pulse, and cardiopulmonary resuscitation was started and continued until the patient reached our hospital. An initial electrocardiogram revealed a normal sinus rhythm with left ventricular hypertrophy and a markedly prolonged QT interval (QTc=635 ms) (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). In the intensive care unit, recurrent episodes of Torsades de Pointes developed, which were terminated spontaneously (<xref ref-type="fig" rid="F1">Fig. 1B</xref>) or by DC shock (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). Echocardiographic assessment revealed severe left ventricular hypertrophy with normal systolic function. The patient did have a past history of primary amenorrhea and had been treated for hypertension with hydrochlorothiazide and valsartan. Initial laboratory evaluation revealed severe hypokalemia of 1.6 mmol/L (reference, 3.5-5.5 mmol/L). Plasma renin activity was decreased (0.13 ng/mL/hr; reference, 0.15-2.23 ng/mL/hr), but aldosterone level was elevated (270.1 pg/dL; reference, 29.9-158.8 pg/dL). Plasma dehydroepiandrosterone (0.8 ng/mL; reference, 1.8-12.5 ng/mL) and cortisol (4.93 ng/mL; reference, 70-250 ng/mL) were decreased, while plasma 11-hydroxycorticosterone (76.0 ug/dL; reference, 8.0-30.0 ug/dL) and ACTH (420.5 pg/mL; reference, 7.2-63.3 pg/mL) were markedly elevated. Follicle stimulating hormone (30.9 mIU/mL; reference, 1.3-8.1 mIU/mL) and luteinizing hormone (19.6 mIU/mL; reference, 1.0-5.3 mIU/mL) were elevated; however, testosterone was undetectable.</p>
      <p>Abdominal computed tomography showed bilateral hyperplasia of adrenal glands (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Chromosome analysis for karyotype showed a 46, XY normal male karyotype, and genomic polymerase chain reaction direct sequencing for CYP17A1 confirmed the diagnosis of 17&#x3B1;-hydroxylase deficiency. After treatment with parenteral replacement of potassium and dexamethasone concurrent with antihypertensive medications, including captopril (300 mg/day), cilnidipine (20 mg/day), and spironolactone (100 mg/day), no more Torsades de Pointes was noted and QTc was normalized (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>We report a case of male pseudohermaphroditism with life-threatening arrhythmia as the first manifested symptom. A deficiency of 17&#x3B1;-hydroxylase is well known to cause male pseudohermaphroditism, combined with hyperaldosteronism. In this case report, hyperaldosteronism due to 17&#x3B1;-hydroxylase deficiency and diuretics might cause severe hypokalemia, leading to Torsades de Pointes. Low extracellular potassium produces hyperpolarization and prolongation of the action potential duration, resulting in Torsades de Pointes triggered activity.<xref ref-type="bibr" rid="B5">5</xref> Moreover, a hypertrophic heart is known to be attributable to baseline increased transmural dispersion of repolarization and is more susceptible to develop Torsades de Pointes.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref> Accordingly, this patient was at a very high risk of life-threatening arrhythmia and, surprisingly, her first presenting symptom was sudden cardiac arrest. Although the majority of cases of sudden cardiac arrest are caused by underlying cardiac disease vulnerable to fatal ventricular arrhythmia, including myocardial infarction with a low ejection fraction or congestive heart failure and electrical disorders,<xref ref-type="bibr" rid="B8">8</xref> several endocrinologic disorders seem to present with sudden cardiac death. In the literature, fatal sudden cardiac arrest as a first manifested symptom was reported in patients with endocrinologic disorders such as anterior pituitary insufficiency and aldosterone producing adrenal adenoma.<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref> Although all of the endocrinologic disorders associated with sudden arrest show a similar mechanism of QT prolongation caused by hypokalemia, their underlying diseases are likely to be heterogeneous. Male pseudohermaphroditism is a rare endocrinologic disorder and sudden cardiac arrest is a very unusual presenting symptom of this disease. To our knowledge, this is the first report of male pseudohermaphroditism presented with sudden cardiac arrest. This case demonstrates that it is important to consider endocrinologic disorders among various causes in the diagnostic work-up, when a patient presents sudden cardiac arrest with a long QT interval.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENTS</title>
      <p>This study was supported in part by a Korean Healthcare Technology Research and Develop grant number A085136, a faculty research grant (6-2009-0176) and a CMB-YUHAN research grant (7-2009-0583) of Yonsei University College of Medicine (BJ).</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors have no financial conflicts of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yanase</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Waterman</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition</article-title>
          <source>Endocr Rev</source>
          <year>1991</year>
          <volume>12</volume>
          <fpage>91</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="pmid">2026124</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sippell</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Wernze</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and treatment of 17-hydroxylase deficiency</article-title>
          <source>J Steroid Biochem Mol Biol</source>
          <year>1993</year>
          <volume>45</volume>
          <fpage>107</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">8481334</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kansui</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Arima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Iida</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Prolongation of the QT interval in primary aldosteronism</article-title>
          <source>Clin Exp Pharmacol Physiol</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>66</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="pmid">15730437</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maule</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mulatero</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Milan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leotta</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Caserta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bertello</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>QT interval in patients with primary aldosteronism and low-renin essential hypertension</article-title>
          <source>J Hypertens</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>2459</fpage>
          <lpage>2464</lpage>
          <pub-id pub-id-type="pmid">17082730</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGowan</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Walters</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Ventricular arrhythmias and hypokalemia</article-title>
          <source>Lancet</source>
          <year>1976</year>
          <volume>2</volume>
          <fpage>964</fpage>
          <pub-id pub-id-type="pmid">62192</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kozhevnikov</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Robotis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Restivo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>El-Sherif</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired torsade de pointes arrhythmias: tridimensional mapping of activation and recovery patterns</article-title>
          <source>Circulation</source>
          <year>2002</year>
          <volume>105</volume>
          <fpage>1128</fpage>
          <lpage>1134</lpage>
          <pub-id pub-id-type="pmid">11877367</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Letsas</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Efremidis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kounas</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Pappas</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Gavrielatos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alexanian</surname>
              <given-names>IP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors</article-title>
          <source>Clin Res Cardiol</source>
          <year>2009</year>
          <volume>98</volume>
          <fpage>208</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="pmid">19031039</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Im</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>WI</given-names>
            </name>
            <name>
              <surname>Joung</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A case of catecholaminergic polymorphic ventricular tachycardia</article-title>
          <source>Yonsei Med J</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>448</fpage>
          <lpage>451</lpage>
          <pub-id pub-id-type="pmid">19568611</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gotyo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Horiuchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hirata</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Torsade de pointes associated with recurrent ampulla cardiomyopathy in a patient with idiopathic ACTH deficiency</article-title>
          <source>Endocr J</source>
          <year>2009</year>
          <volume>56</volume>
          <fpage>807</fpage>
          <lpage>815</lpage>
          <pub-id pub-id-type="pmid">19506326</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aydin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Okmen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Erdinler</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sanli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cam</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Adrenal adenoma presenting with ventricular fibrillation</article-title>
          <source>Tex Heart Inst J</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>85</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">15902830</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>ECG and arterial blood pressure recording. (A) The 12-lead ECG at the emergency room shows a markedly prolonged QT interval (QTc=635 ms). (B) Spontaneous termination of Torsades de Pointes. Note the short-long-short initiation of polymorphic ventricular tachycardia. (C) Torsades de Pointes with hemodynamic compromise, which was terminated by biphasic shock of 100 J. The ABP waveform became flat after the occurrence of Torsades de Pointes. ABP, arterial blood pressure; ECG, electrocardiogram.</p>
      </caption>
      <graphic xlink:href="ymj-53-658-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Abdominal computed tomography showed bilateral hyperplasia of adrenal glands (arrows).</p>
      </caption>
      <graphic xlink:href="ymj-53-658-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>Clinical course of the patient. Serial variations in plasma ACTH, systolic blood pressure (SBP), corrected QT interval (QTc), serum cortisol, and potassium (K<sup>+</sup>) are shown. ACTH, adrenocorticotropic hormone; HD, hospital day.</p>
      </caption>
      <graphic xlink:href="ymj-53-658-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
